Can Reducore Support Metabolic Health and Muscle Preservation in Long COVID?

To understand how Reducore functions, we must first look at the natural, healthy state of human metabolism. Metabolic resilience is not just about weight; it is the body's ability to efficiently adapt to energy demands, process nutrients without excessive physiological stress, and maintain cellular homeostasis. This resilience relies on a delicate, interconnected triad: a thriving gut microbiome, stable glycemic control, and the preservation of lean muscle mass. When these three systems work in harmony, the body can efficiently extract energy from food, regulate appetite hormones, and repair tissues.

Reducore is scientifically formulated to address this exact triad. Rather than relying on a single mechanism, it utilizes three distinct, synergistic blends of clinically studied ingredients. The first is the BiomeFuel Blend, which focuses on the gut-metabolism axis. The second is the Glycemic Control Blend, designed to modulate how the body processes carbohydrates and lipids. The third is the Muscle Support Blend, which targets cellular pathways to maintain lean body mass even in the absence of strenuous exercise. Together, these blends aim to restore the metabolic flexibility that is often lost in chronic illness.

The foundation of Reducore is its BiomeFuel Blend, which contains 5 grams of specialized, digestion-resistant fibers: Resistant Tapioca Dextrin (FiberSMART®), Resistant Potato Starch (Solnul®), and Acacia and Carob Fiber (Inavea™). In a healthy digestive system, these complex carbohydrates bypass early digestion in the stomach and small intestine, arriving intact in the colon. Here, they serve as prebiotics—essential food for beneficial gut bacteria such as Bifidobacterium and Akkermansia muciniphila.

When these specific bacteria ferment the resistant starches, they produce short-chain fatty acids (SCFAs), most notably butyrate. Butyrate is a critical signaling molecule. It provides the primary energy source for the cells lining the colon (colonocytes), maintaining the integrity of the intestinal barrier. Furthermore, butyrate binds to specific G-protein coupled receptors (such as FFAR2 and FFAR3) on the L-cells of the intestinal lining. This binding triggers the natural, endogenous release of GLP-1 (glucagon-like peptide-1) and PYY (peptide YY). These hormones travel to the brain to signal profound, lasting satiety, while also instructing the pancreas to optimize insulin secretion, thereby naturally regulating appetite and blood sugar.

The second pillar of Reducore is the Glycemic Control Blend, featuring Mulberry Leaf Extract (Reducose®), Berberine Phytosome (Berbevis®), and Bergamot Phytosome (Vazguard®). Reducose is a patented water extract of white mulberry leaf, standardized to contain a specific iminosugar called 1-deoxynojirimycin (DNJ). At the molecular level, DNJ closely resembles a glucose molecule. When you consume carbohydrates, DNJ competitively binds to alpha-glucosidase—the enzyme in the small intestine responsible for breaking down complex carbs into absorbable simple sugars. By temporarily occupying this enzyme, Reducose delays carbohydrate digestion, smoothing out the post-meal glucose spike and preventing the subsequent crash that leaves patients feeling exhausted.

Complementing this is Berbevis, a highly bioavailable form of berberine. Traditional berberine is a powerful metabolic botanical, but it is notoriously difficult for the body to absorb. Berbevis utilizes advanced phytosome technology, binding the berberine to sunflower lecithin and pea protein, which increases its absorption by nearly ten times. Once in the bloodstream, berberine acts as a systemic metabolic master switch by activating AMP-activated protein kinase (AMPK). AMPK activation stimulates cells to pull glucose out of the blood and burn it for energy, effectively improving insulin sensitivity at the cellular level.

The final component is the Muscle Support Blend, which features Amino L40®, a patented, vegan-friendly blend of all nine essential amino acids. What makes Amino L40 unique is its "golden ratio"—it is composed of exactly 40% L-leucine. L-leucine is a branched-chain amino acid (BCAA) that acts as the primary chemical trigger for muscle protein synthesis.

At the cellular level, L-leucine directly activates the mTOR (Mechanistic Target of Rapamycin) signaling pathway. The mTOR pathway is the body's central regulator of cell growth and protein synthesis. By delivering a highly concentrated, rapidly absorbed dose of L-leucine alongside the other essential building blocks, Amino L40 bypasses the need for large amounts of dietary protein. It essentially "hacks" the body's anabolic signaling, shifting the net protein balance from muscle breakdown (catabolism) to muscle repair and preservation (anabolism). Reducore also includes 50 mg of Magnesium Glycerophosphate, a highly absorbable form of magnesium that supports cellular energy production (ATP) and proper muscle relaxation.

To understand why a multi-dimensional metabolic supplement is relevant, we must examine how conditions like Long COVID and ME/CFS dismantle the body's natural resilience. Recent scientific research has established a profound connection between post-viral syndromes, gut microbiome dysbiosis, and systemic metabolic dysfunction. In healthy individuals, the gut microbiome is diverse and balanced. However, in patients with Long COVID and ME/CFS, this balance is severely disrupted.

Studies consistently show a significant depletion of health-promoting, butyrate-producing bacteria in these patient populations. For instance, a landmark 2025 AI-driven study by The Jackson Laboratory found that patients with ME/CFS had profoundly lower levels of gut-produced butyrate. Without sufficient butyrate, the intestinal lining degrades, leading to increased intestinal permeability, commonly known as "leaky gut." Furthermore, research indicates that SARS-CoV-2 can persist in the gut by binding to ACE2 receptors. This viral persistence, combined with a leaky gut, allows endotoxins and undigested proteins to enter the bloodstream, triggering chronic, systemic inflammation and activating mast cells, a hallmark of mast cell activation syndrome (MCAS).

This chronic, low-grade inflammation creates a devastating bio-feedback loop that drives severe metabolic dysfunction, specifically insulin resistance. When the body is in a constant state of immune alarm, it releases stress hormones like cortisol and catecholamines. These hormones naturally elevate blood sugar levels to provide quick energy for a "fight or flight" response. Over time, the continuous presence of high blood sugar and inflammatory cytokines causes the body's cells to downregulate their insulin receptors. They become "deaf" to insulin's signal, refusing to let glucose inside.

This insulin resistance is catastrophic for cellular energy. Even if a patient is eating well, their cells are essentially starving because glucose cannot enter the mitochondria to be converted into ATP (cellular energy). Metabolomic studies on Long COVID patients have identified blood metabolites strongly linked to impaired glucose control, with many patients developing new-onset insulin resistance following their infection. When neurons in the brain cannot efficiently utilize glucose due to systemic insulin resistance, it results in neuroinflammation and the profound cognitive decline commonly referred to as "brain fog."

Perhaps one of the most frustrating aspects of living with Long-Term COVID or ME/CFS is the rapid loss of muscle mass and the profound weakness that accompanies it. This is driven by a phenomenon known as anabolic resistance. Chronic inflammation and insulin resistance blunt the body's ability to utilize dietary protein to build or repair muscle. The mTOR pathway, which normally triggers muscle synthesis, becomes suppressed by the constant inflammatory signaling.

Compounding this issue is the reality of post-exertional malaise (PEM). Because patients experience severe symptom exacerbation after physical activity, they are often forced into prolonged periods of rest or bedbound states. This lack of mechanical loading on the muscles accelerates atrophy. Furthermore, research into ME/CFS has revealed a significantly reduced rate of ATP synthesis by mitochondrial Complex V in peripheral blood mononuclear cells. When the cells cannot produce enough energy to sustain basic metabolic functions, the body begins to break down its own muscle tissue (catabolism) to harvest amino acids for emergency fuel, creating a vicious cycle of weakness and fatigue.

Reducore is designed to intervene in these vicious cycles by providing targeted support to the disrupted pathways. The first step in restoring metabolic resilience is healing the gut-metabolism axis. The BiomeFuel Blend in Reducore delivers a precise combination of resistant starches and prebiotics that specifically nourish the depleted populations of butyrate-producing bacteria. By feeding strains like Faecalibacterium prausnitzii and Bifidobacterium, the resistant tapioca dextrin and potato starch encourage a rapid increase in SCFA production.

This surge in butyrate serves multiple therapeutic purposes. First, it provides the necessary fuel for colonocytes to repair the intestinal barrier, helping to seal the "leaky gut" and halt the systemic influx of inflammatory endotoxins. Second, the increased SCFA production binds to receptors on the intestinal L-cells, stimulating the natural, endogenous release of GLP-1. Unlike synthetic GLP-1 agonist medications, which can cause severe gastrointestinal distress, this natural stimulation promotes gentle, sustained satiety, helps regulate gastric emptying, and improves the pancreas's ability to manage insulin, addressing the root of the metabolic dysfunction.

To combat the cellular energy starvation caused by insulin resistance, Reducore utilizes its Glycemic Control Blend to attack the problem from two angles: digestion and cellular uptake. In the digestive tract, the Reducose (mulberry leaf extract) acts as a temporary shield. By competitively inhibiting the alpha-glucosidase enzyme, the 1-deoxynojirimycin (DNJ) prevents complex carbohydrates from being rapidly cleaved into simple sugars. This means that instead of a massive influx of glucose flooding the bloodstream and triggering a panicked release of insulin, the glucose is absorbed slowly and steadily over several hours.

Systemically, the Berbevis (berberine phytosome) works to repair the cells' responsiveness to insulin. By activating the AMPK pathway, berberine acts as an exercise mimetic—it signals the cells to behave as if the body is engaging in physical activity. This activation forces the translocation of GLUT4 transporters to the cell membrane, allowing glucose to enter the cell and reach the mitochondria independently of insulin. By lowering circulating blood glucose and reducing the demand on the pancreas, berberine helps break the cycle of stress-induced hyperglycemia and cellular starvation, potentially alleviating the reactive hypoglycemia and brain fog that plague many patients.

For patients who cannot exercise due to severe PEM or dysautonomia, preserving muscle mass is a monumental challenge. This is where the Amino L40 in Reducore's Muscle Support Blend becomes crucial. Because chronic illness induces anabolic resistance, standard dietary protein is often insufficient to trigger muscle repair; the inflammatory blockade is simply too strong.

Amino L40 overcomes this blockade by delivering a highly concentrated, rapidly absorbed dose of L-leucine. L-leucine is unique among amino acids because it directly interacts with the mTORC1 complex inside the muscle cells. When the concentration of intracellular L-leucine spikes, it forcefully activates mTOR, signaling the cell to initiate translation and build new muscle proteins. Clinical studies have demonstrated that a very small dose (just 3 grams) of this specific leucine-enriched amino acid profile can stimulate muscle protein synthesis to the same degree as a massive 20-gram bolus of whey protein. This allows patients to maintain lean body mass and support metabolic rate without the need for strenuous exercise or consuming large, heavy meals that their compromised digestive systems cannot handle.

Because Reducore targets the foundational pillars of metabolism—gut health, blood sugar regulation, and muscle integrity—it may help manage a wide array of interconnected symptoms experienced by individuals with complex chronic conditions. While it is not a cure, supporting these biochemical pathways can significantly improve daily quality of life.

When evaluating metabolic supplements, bioavailability—the amount of the active ingredient that actually enters systemic circulation—is paramount. Traditional berberine, while powerful, has notoriously poor absorption; the body quickly metabolizes it in the gut and liver before it can reach the target cells. Reducore circumvents this issue by utilizing Berbevis®, a patented berberine phytosome.

Phytosome technology involves binding the berberine extract to natural phospholipids (specifically sunflower lecithin), pea protein, and grape seed extract. This lipid matrix mimics the structure of human cell membranes, allowing the berberine to easily pass through the intestinal wall. Clinical data from the manufacturer demonstrates that this technology increases berberine's absorption by nearly ten times compared to standard unformulated extracts. This means patients can achieve significant metabolic benefits at a much lower dose, avoiding the gastrointestinal upset (such as diarrhea and cramping) frequently associated with high doses of standard berberine.

Because Reducore is designed to manage the body's response to incoming nutrients, timing is critical. The suggested use is to mix one scoop (8.1 grams) with 2 to 4 ounces of water or a preferred beverage immediately before meals. Taking it pre-meal allows the Reducose (mulberry leaf extract) to position itself in the small intestine, ready to inhibit the alpha-glucosidase enzymes before the carbohydrates arrive. It also gives the prebiotic fibers time to begin interacting with the gut microbiome.

A crucial practical consideration is temperature. Ortho Molecular explicitly warns that Reducore must be mixed with liquids below 140°F (60°C). Using hot liquids, such as hot tea or coffee, can denature the delicate amino acids in the Amino L40 blend and degrade the functional prebiotic fibers and botanical extracts, rendering the formula ineffective. It is best mixed in cold or room-temperature water. The formula includes natural non-glycemic sweeteners like allulose and stevia extract (Rebaudioside M) to provide a palatable peach-mango flavor without spiking blood sugar.

While Reducore is formulated with safety and tolerability in mind, its powerful effects on blood sugar necessitate careful consideration. Because berberine and mulberry leaf extract actively lower blood glucose and improve insulin sensitivity, individuals currently taking prescription blood sugar-lowering medications (such as metformin, insulin, or sulfonylureas) must consult their healthcare provider before starting Reducore. Combining these supplements with pharmaceutical hypoglycemics can increase the risk of blood sugar dropping too low (hypoglycemia).

Additionally, while the prebiotic fibers in the BiomeFuel blend are designed to be gentle and well-tolerated, individuals with severe Small Intestinal Bacterial Overgrowth (SIBO) or highly sensitive digestive systems may experience initial bloating or gas as their microbiome adjusts to the new fiber sources. In such cases, a practitioner may recommend starting with a partial scoop and gradually titrating up to the full dose to allow the gut bacteria to adapt slowly. As always, patients navigating complex conditions like Long COVID should integrate new supplements under the guidance of a knowledgeable medical professional.

The individual components of Reducore are backed by robust clinical research, particularly regarding their effects on metabolic dysfunction. The efficacy of Berbevis (berberine phytosome) was demonstrated in a 60-day randomized, double-blind, placebo-controlled trial involving patients with impaired fasting glucose. Participants taking the phytosome formulation showed significant improvements in fasting blood glucose and a marked reduction in the HOMA index, a primary clinical marker for insulin resistance. Furthermore, the study noted statistically significant reductions in visceral fat mass and improvements in lipid profiles, confirming berberine's systemic impact on metabolic health.

Additional research highlights berberine's broader endocrine benefits. A 2023 multi-centric, randomized controlled trial investigated the use of Berbevis in women with Polycystic Ovary Syndrome (PCOS), a condition deeply intertwined with severe insulin resistance. After 90 days, the majority of participants experienced normalized ovarian anatomy and improved hormonal balance, driven by the profound enhancement of insulin sensitivity and the subsequent reduction of excess androgens.

The immediate glycemic benefits of Reducose (mulberry leaf extract) have been validated in multiple human trials. A 2024 double-blind, randomized crossover trial tested various doses of Reducose alongside a complex carbohydrate meal. The researchers found that the extract lowered the postprandial (post-meal) glucose curve by over 30% compared to a placebo. Crucially, it also reduced the insulin response by up to 38%, indicating that the pancreas had to work significantly less to manage the meal, thereby preserving pancreatic beta-cell function and preventing reactive hypoglycemia.

In the realm of muscle preservation, the Amino L40 blend has shown remarkable efficacy in overcoming anabolic resistance. A landmark study published in the American Journal of Physiology-Endocrinology and Metabolism evaluated the muscle-building effects of this specific leucine-enriched essential amino acid profile in older adults facing age-related muscle loss. The researchers discovered that a mere 3-gram dose of the Amino L40 blend stimulated muscle protein synthesis equivalently to a massive 20-gram dose of standard whey protein. This profound efficiency makes it an invaluable tool for patients with Long COVID or ME/CFS who suffer from severe fatigue, low appetite, and the inability to engage in resistance training.

Finally, the rationale for the BiomeFuel prebiotic blend is strongly supported by emerging research into the pathophysiology of post-viral syndromes. A 2025 AI-driven study by The Jackson Laboratory utilized advanced machine learning to analyze the microbiomes of individuals with ME/CFS. The data conclusively showed that these patients suffer from a severe depletion of butyrate-producing bacteria. By supplying the specific resistant starches needed to cultivate these exact bacterial strains, Reducore directly targets the dysbiosis that drives systemic inflammation and metabolic collapse in chronic illness.

Navigating the daily realities of a complex chronic illness is an exhausting, often deeply frustrating journey. When your body seems to lose its ability to process energy, maintain muscle, and regulate basic metabolic functions, it is easy to feel betrayed by your own biology. Validating these physical changes is the first step toward reclaiming your health. The sudden weight fluctuations, the intense fatigue after eating, and the profound muscle weakness are not in your head—they are the tangible results of post-viral metabolic dysfunction, insulin resistance, and microbiome dysbiosis.

While there is no single miracle cure for conditions like Long COVID, ME/CFS, or dysautonomia, restoring metabolic resilience is a critical component of a comprehensive management strategy. By systematically addressing the triad of gut health, glycemic control, and muscle integrity, multi-dimensional formulations like Reducore can help rebuild the foundation of cellular energy. When combined with careful pacing, symptom tracking, a tailored anti-inflammatory diet, and the guidance of a compassionate medical team, targeted nutritional support can help break the vicious cycles of inflammation and exhaustion.

If you are struggling with metabolic instability, reactive hypoglycemia, or muscle wasting as part of your chronic illness journey, it may be time to explore comprehensive metabolic support. Always consult with your healthcare provider to ensure new supplements align with your current medications and treatment plan.